期刊文献+

结直肠癌患者血清淋巴管内皮生长因子检测及其临床意义 被引量:2

Serum Vascular Endothelial Growth Factor-C and Vascular Endothelial Growth Factor Level in Patients with Colorectal Carcinoma and Their Clinical Significance
下载PDF
导出
摘要 目的检测结直肠癌患者血清淋巴管内皮生长因子(VEGF-C)和血管内皮生长因子(VEGF)的水平,评估它们作为诊断和监测结直肠癌患者淋巴结转移指标的临床意义。方法应用酶联免疫吸附试验(ELISA)检测66例结直肠癌患者、22例健康对照者血清中VEGF-C和VEGF的水平。结果结直肠癌患者血清VEGF-C的浓度为(1 688.02±325.02)pg/ml,明显高于健康对照组[(948.68±250.52)pg/ml](P<0.01)。结直肠癌淋巴结转移组血清VEGF-C的浓度高于无淋巴结转移组;按照有无淋巴管浸润和血管浸润分组,VEGF-C水平在浸润组中高于无浸润组。血清VEGF-C水平>1 439.7 pg/ml预测淋巴结转移的灵敏度和特异性分别达80.0%和77.8%;而血清VEGF水平>237.2pg/ml预测淋巴结转移的灵敏度和特异性分别达73.3%和72.2%;VEGF-C和VEGF水平联合检测,淋巴结转移阳性率的预测价值达84.6%,而阴性率的预测价值达94.7%。结论血清VEGF-C水平可为结直肠癌患者淋巴结是否转移提供新的诊断依据。血清VEGF-C和VEGF水平的联合检测可作为结直肠癌患者术前临床分期的重要指标。 Objective To measure circulating vascular endothelial growth factor-C(VEGF-C)and vascular endothelial growth factor(VEGF)levels in patients with colorectal carcinoma,and assess their clinical significance as a diagnostic tool for determining lymph node metastasis.Methods In 66 patients with colorectal carcinoma and 22 healthy controls,circulating VEGF-C and VEGF levels were assessed by enzyme-linked immunosorbent assay.Results Serum VEGF-C and VEGF levels were higher in patients with colorectal carcinoma than in healthy controls.Patients with lymph node metastasis revealed higher serum VEGF-C and VEGF levels than those without lymph node metastasis.The levels of VEGF-C and VEGF in the patients with lymphatic vessel invasion and venous invasion were higher than in those without invasion.Serum VEGF-C levels reached a sensitivity of 80.0% and a specificity of 77.8% with a cutoff value of 1 439.7 pg/ml,whereas VEGF levels reached 73.3% sensitivity and 72.2% specificity at 237.2 pg/ml.By th多e combined detection of VEGF-C and VEGF levels,the positive and negative predictive value for lymph node metastasis was 84.6% and 94.7% respectively.Conclusion Circulating VEGF-C levels may provide additional information for judgment of lymph node metastasis in patients with colorectal carcinoma.The combined detection of VEGF-C and VEGF levels can be acted as an important index for clinical stage of colorectal carcinoma.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2009年第6期840-843,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 福建省科技厅青年人才创新基金资助项目(No.2006F3046)
关键词 结直肠癌 淋巴管内皮生长因子 淋巴结转移 colorectal carcinoma vascular endothelial growth factor-C lymph node metastasis
  • 相关文献

参考文献2

二级参考文献11

  • 1计骏,严超,张俊,于颖彦,张奕,纪玉宝,刘炳亚,朱正纲,尹浩然,林言箴.血管内皮生长因子-C在胃癌中的表达及其与淋巴结转移的关系[J].中华实验外科杂志,2004,21(5):530-532. 被引量:13
  • 2王勇杰,刘相萍,沈毅,吕振华,隋爱华,杨堃,王善政.血管内皮生长因子-C及其受体3mRNA在肺癌及癌旁组织中的表达与临床意义[J].中华实验外科杂志,2004,21(11):1322-1323. 被引量:6
  • 3许天文,陈道达,陈剑英,郑勇斌,连彦军.血管内皮生长因子-C在大肠癌中的表达及其与淋巴结转移的关系[J].中华实验外科杂志,2005,22(5):598-600. 被引量:19
  • 4Takeda A,Shiimada H,Imaseki H,et al.Clinical significance of serum vascular endothelial growth factor in colorectal cancer patients:correlation with clinical-pathological factors and tumor marders[J].Oncol Rep,2000,7(2):333-338.
  • 5Kaya A,Ciledag A,Gulbay BE,et al.The prognostic significance of vascular endothelial growth factor levels in sera of nonsmall cell lung cancer patients [J].Respir Med,2004,98(7):632-636.
  • 6Tamura M,Ohta Y.Serum vascular endothelial growth factor-C level in patients with primary non-small cell lung carcinoma;a possible diagnostic tool for lymph mode metastasis [J].Cancer,2003,98(6):1217-1222.
  • 7Tamura M,Oda M,Matsumoto I,et al.The combination assay with circulating vascular endothelial growth factor (VEGF)-C,matrix metalloproteinase-9,and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer [J].Ann Surg Oncol,2004,11(10):928-933.
  • 8Weidner N.Current pathologic methods for measuring intratumoral microvessled ensity within breast carcinoma and other solid tumors[J].Breast Cancer Res Treat,1995,36(2):169-173.
  • 9Tille JC,Nisato R,Pepper MS.Lymphangiogenesis and tumour metastasis[J].Novartis Found Symp,2004,256(1):112-131.
  • 10Gerber HP,Ferrara N.Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies [J].Cancer Res,2005,65 (3):671-680.

共引文献9

同被引文献21

  • 1许天文,陈道达,陈剑英,郑勇斌,连彦军.血管内皮生长因子-C在大肠癌中的表达及其与淋巴结转移的关系[J].中华实验外科杂志,2005,22(5):598-600. 被引量:19
  • 2Roth BJ, Krilov 1., Adams S, et al. Clinical cancer advances 2012: annual report ,m progress against cancer from the american society of clinical oncology[J]. J Clin Oncol, 2013, 31(1):131-161.
  • 3Rahlmri NN. Bork U. Motschall E, et al. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis[J]. J Clin Oncol, 2012, 30( 1 ):60-70.
  • 4He K, Cui B, Li G, et al. The effect of anti-VEGF drugs (hevacizumab and aflibercept) on the survival of" patients with melastatic colorectal cancer (mCRC)[J]. Onto Targets Ther, 2012, 5:59-65.
  • 5Tsm&alas N, Tzovaras AA, Tolia M, et al. Meta-analysis of the predictive value of KRAS mutations in treatment response using cetuximab in cohorectal cancer[J]. J BUON, 2012, 17(1):73-78.
  • 6Karkkainen M J, Makinen T, Alitalo K. Lymphatic endothelium: a new frontier of metastasis re.search[J]. Nat Cell Biol, 2002, 4(1):E2-5.
  • 7孙燕.临床肿瘤学高级教材[M].北京:人民军医出版社,2011:533-534.
  • 8Karkkainen MJ, Saaristo A, Jussila L, et al. A model for gene therapy of human hereditary lymphedema[J]. Proc Natl Acad Sci U S A, 2001,98(22):12677-12682.
  • 9Jain RK, Padera TP. Prevention and treatmem of lymphatic metastasis by antilymphangiogenic therapy [J]. J Natl Cancer lnst, 2002, 94(11):785-787.
  • 10Hanrahan V, Currie M J, Gunningham SP, et al. The angiogenic swilch for vascular endothelial growth factor (VEGF)-A, VE(,F-B, VEGF-C, and VEGF-D in the adenoma- carcinoma sequence during colorectal cancer progression[J]. J Pathol, 2003, 200(2): 183-194.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部